Yesterday, the President & CEO of VolitionRX (VNRX – Research Report), Cameron John Reynolds, bought shares of VNRX for $11K.
Tag: NYSE MKT:VNRX
VolitionRX (VNRX) Gets a Buy Rating from Oppenheimer
In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Buy rating to VolitionRX (VNRX – Research Report), with
Maxim Group Issues a Buy Rating on VolitionRX (VNRX)
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to VolitionRX (VNRX – Research Report),
Maxim Group Sticks to Its Buy Rating for VolitionRX (VNRX)
Maxim Group analyst Jason McCarthy maintained a Buy rating on VolitionRX (VNRX – Research Report) today and set a price
A Director at VolitionRX (NYSE MKT: VNRX) is Buying Shares
Today, a Director at VolitionRX (VNRX – Research Report), Martin Charles Faulkes, bought shares of VNRX for $197K. Following this
VolitionRX (VNRX) Gets a Buy Rating from Maxim Group
In a report issued on August 13, Jason McCarthy from Maxim Group maintained a Buy rating on VolitionRX (VNRX –
Maxim Group Reaffirms Their Buy Rating on VolitionRX (VNRX)
Maxim Group analyst Jason McCarthy maintained a Buy rating on VolitionRX (VNRX – Research Report) today and set a price